Experimental Procedures.

Chemoenzymatic synthesis of S-NAD
Scheme S1. Chemoenzymatic synthesis of S-NAD + .
Materials and Methods.
1 H NMR spectra were recorded on an Oxford AM-400 spectrometer for solution in CDCl 3 , CD 3 OD or D 2 O. Coupling constants J are shown in Hz. 13 C NMR spectra were recorded on an Oxford AM-400 spectrophotometer (100 MHz) with a complete proton decoupling spectrophotometer (CDCl 3 : 77.0 ppm). Flash column chromatography was performed using 230-400 mesh silica gel (Sigma-Aldrich, St.
Louis, MO). For thin-layer chromatography (TLC), silica gel plates (Sigma-Aldrich GF254) were used. HPLC was performed on a Waters 2487 series with a C18 Kinetex column (5 µm, 100 Å, 150×10.0 mm, from Phenomenex Inc, Torrance, CA). All other reagents were purchased from readily available commercial sources and used without further purification. mmol, 2 eq) followed by the addition of concentrated H 2 SO 4 (266 L, 0.1 eq) at 0 o C.
Then, the reaction mixture was allowed to warm to room temperature and stirred at the same temperature for 24 hours. The pH of the solution was adjusted to 7 with NaHCO 3 , and the resulting slurry was filtered and evaporated to give a residue. The residue was dissolved in ethyl ether (200 mL) and washed with water (3×50 mL), dried over anhydrous Na 2 SO 4 , filtered and concentrated to give the compound 2 (8.0 g, 62%) as a colorless oil. General procedure for the synthesis of compound 3. To a stirred solution of compound 2 (4.5 g, 17.4 mmol) in anhydrous THF (50 mL) was added LiAlH 4 (9.9 mL, 34.8 mmol, 2 eq, a 3.5 M solution in THF) in several portions at 0 o C. Then, the S4 reaction mixture was allowed to warm to room temperature and stirred at the same temperature for 8 hours. The reaction mixture was then quenched with ice, dried over anhydrous MgSO 4 , filtered through a celite pad and evaporated to give a residue. The residue was dissolved in pyridine (20 mL) and the mixture was cooled to 0 o C. MsCl (6.8 mL, 52.2 mmol, 3 eq) was added dropwise and the resulting mixture was then allowed to warm to room temperature. After stirring for 16 hours, the reaction was quenched with MeOH (10 mL) and the mixture was concentrated under reduced pressure to give a residue. The residue was dissolved in EtOAc (50 mL), and the organic phase was washed successively with saturated aqueous CuSO 4 (3×50 mL), brine (50 mL), dried over anhydrous Na 2 SO 4 , filtered, concentrated and purified by a flash column chromatography on silica gel to afford the compound 3 (5.8 g, 80%) as a colorless oil. General procedure for the synthesis of compound 4. To a stirred solution of compound 3 (5.8 g, 13.9 mmol) in DMF (100 mL) was added sodium sulfide nonahydrate (4.0 g, 16.7 mmol, 1.2 eq) and the reaction mixture was heated to 100 o C for 18 h. After being cooled to room temperature, the mixture was diluted with ethyl ether (300 mL) and washed with water (5×50 mL) and brine (50 mL). The organic layer was dried over anhydrous Na 2 SO 4 , filtered, concentrated and purified by a flash column chromatography on silica gel to afford the compound 4 (2.3 g, 64%) as a colorless oil. was dissolved in 30% aqueous AcOH (60 mL) and the resulting mixture was stirred at room temperature for 6 h. The reaction was then concentrated under reduced pressure to give a residue. The residue was purified by a flash column chromatography on silica gel to afford the compound 5 (599 mg, 34%) as a colorless oil. 1-((3aS,4R,6aR) General procedure for the synthesis of compound 9. Compound 8 (310 mg, 1.0 mmol) was dissolved in AcOH (10 mL) and the mixture was heated to 100 o C for 8 h. Then, the reaction was concentrated to give a residue. The residue was dissolved in EtOAc (80 mL), and the organic phase was washed successively with saturated aqueous NaHCO 3 (3×10 mL), brine (20 mL), dried over anhydrous Na 2 SO 4 , filtered, concentrated and purified by a flash column chromatography on silica gel to afford S10 the compound 9 (190 mg, 54%) as a colorless oil. 
(3aR,6S,6aR)-6-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one (2)
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General procedure for the synthesis of compound 3. Compound 9 1 (106 mg, 0.3 mmol) was dissolved in toluene (10 mL) and cooled to 0 o C. HBr (33% (wt) in acetic acid) (110 mg, 0.45 mmol, 1.5 eq) was added dropwise and the reaction was stirred at 0 o C for 5 hours. After the starting material was consumed, the reaction was concentrated under reduced pressure to give a residue. The residue was azeotroped with toluene (3×20 mL) to remove remaining acetic acid and dried in vacuo. The crude product and nicotinamide (44 mg, 0.36 mmol, 1.2 eq) was dissolved in CH 3 CN (10 mL). The reaction was stirred under Ar gas at room temperature for 24 hours. The reaction was concentrated in vacuo (the temperature was kept below 35 o C) and S11 purified by a flash column chromatography on silica gel to afford the desired compound 10 (86 mg, 58% yield) as a colorless solid. 
1-((3aR,4R,6R,6aS)-6-((benzoyloxy
3-carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl)pyridin-1-ium (S-NR
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Enzymatic Conversion of S-NR to S-NAD + .
Human nicotinamide riboside kinase 1 (NRK1) and nicotinamide mononucleotide adenylyltransferase 1 (NMNAT1) were expressed and purified based on previous publications. 2, 3 Table S1. List of primer sequences used for molecular cloning of human NRK1 and NMNAT1. Restriction enzyme sites for NcoI and XhoI are underlined and in italics.
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Name Sequence
Protein sequences of human NRK1 and NMNAT1: Figure S1
. SDS-PAGE gel of the purified human NRK1 and NMNAT1.
Purified S-NR (0.5 mg in the form of bromide salt) was incubated with 6 mM ATP, 5 uM of purified NRK1 and NMNAT1 at the final concentration of 2 mM at room temperature for overnight in the reaction buffer (50 mM Tris, 100 mM NaCl, 12 mM , 1 mM DTT, and pH 7.5). After centrifugation at 4,000 g for 5 minutes, NGD + (Sigma-Aldrich, MO) was used as a substrate to determine ADP-ribosyl cyclase activity of purified CD38, because cyclic GDP-ribose (cGDPR) product is characterized by distinctive UV absorbance at 295 nm and fluorescence emission at 410 nm (excitation at 300 nm). 5 To characterize kinetic parameters, reactions were initiated by additions of recombinant CD38 (8. 
HPLC analysis of reduction of NAD + and S-NAD + by redox enzymes.
To examine the bovine GDH-catalyzed reactions, 0.5 mM NAD + or S-NAD + was incubated with 2 mM L-glutamate and 20 unit/ml GDH in buffer containing 2 mM DTT, 50 mM Tris, pH 7.5 for 30 minutes at room temperature, followed by HPLC analysis with detection of UV absorbance at 340 nm. To evaluate the L. mesenteroides G6PDH-catalyzed reactions, 0.5 mM NAD + or S-NAD + was incubated with 5 mM D-glucose 6-phosphate and 10 unit/ml G6PDH in buffer containing 5 mM MgCl 2 , 50 mM Tris, pH 7.5 for 30 minutes at room temperature, followed by HPLC analysis with detection of UV absorbance at 340 nm. The HPLC method used for analysis of reactions by GDH and G6PDH was the same as described above. Single crystals appeared after 5 days and grew to their maximum size within 10-40 days. The best crystals grew in 100 mM HEPES, pH 7.0, 14-18% PEG 4000 at 22°C.
Crystals were dipped into a 10% glycerol cryosolution and were flash-frozen in liquid nitrogen before they were mounted for data collection.
X-Ray diffraction data collection and structure determination.
Data was collected at Synchrotron Radiation Light Source (SSRL) using beamline 12-2 equipped with a Dectris-Pilatus 6M detector. The collected data were indexed and integrated with XDS and scaled using Scala, a part of the CCP4 suite. [8] [9] [10] Initial phase information was obtained by molecular replacement using PHASER with the previously solved structure of human cyclic-ADP-ribosyl synthetase/NAD + glycohydrolase (PDB ID code 1ZVM) as the search model. 11 Waters were added S34 using ArpWarp during the initial round of the refinement. [12] [13] [14] The Ligand was built using Ligand Builder in Coot and restrain generation and optimization by elbow part of Phenix Crystallography suit and also ProDrg part of CCP4 suit. 9, [14] [15] [16] The structure was improved by iterative rounds of model building and refinement using the programs Coot and Refmac5. 13, 14 The crystals belong to space group P1 2 1 1 and it contains two molecules per asymmetric unit. Crystallographic details and statistics are listed in Table S2 . and active CD38 (grey) with indicated key interacting residues.
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